Cell Source, Inc. (CLCS)

Cell Source Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	2023	2022	2021	2020	2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	0.09	0.02	0.22	0.09	0.24	0.03
Cash & Short-Term Investments	0.09	0.02	0.22	0.09	0.24	0.03
Cash Growth	311.72%	-90.03%	139.18%	-61.47%	765.77%	47.40%
Prepaid Expenses	0.32	0.16	0.16	0.2	0.18	0.06
Other Current Assets	0.02	0.01	0.02	0.02	0.03	0.03
Total Current Assets	0.43	0.2	0.41	0.31	0.45	0.11
Other Long-Term Assets	-	-	-	-	0	-
Total Assets	0.43	0.2	0.41	0.31	0.45	0.11
Accounts Payable	1.75	1.47	0.68	0.22	0.19	0.14
Accrued Expenses	5.36	4.75	4.22	3.12	3.08	2.42
Short-Term Debt	9.02	8.22	7	4.66	3.31	1.59
Current Portion of Long-Term Debt	0.98	1.08	0.91	1.83	1.49	0.97
Other Current Liabilities	0.63	0.29	0.24	0.3	0.32	0.6
Total Current Liabilities	17.75	15.81	13.04	10.14	8.4	5.71
Long-Term Debt	-	-	-	-	-	0.15
Total Liabilities	17.75	15.81	13.04	10.14	8.4	5.86
Common Stock	0.04	0.04	0.04	0.03	0.03	0.03
Additional Paid-In Capital	27.07	26.01	23.67	21.32	17.72	15.38
Retained Earnings	-44.43	-41.67	-36.35	-31.18	-25.71	-21.15
Total Common Equity	-17.32	-15.61	-12.64	-9.83	-7.95	-5.74
Shareholders' Equity	-17.32	-15.61	-12.63	-9.83	-7.95	-5.74
Total Liabilities & Equity	0.43	0.2	0.41	0.31	0.45	0.11
Total Debt	10.01	9.3	7.9	6.5	4.81	2.7
Net Cash (Debt)	-9.92	-9.27	-7.68	-6.4	-4.56	-2.67
Net Cash Per Share	-0.25	-0.25	-0.22	-0.19	-0.16	-0.09
Filing Date Shares Outstanding	41.94	41.02	38.16	34.44	32.66	27.08
Total Common Shares Outstanding	41.94	39.83	36.08	34.36	32.54	27.08
Working Capital	-17.32	-15.61	-12.63	-9.83	-7.95	-5.6
Book Value Per Share	-0.41	-0.39	-0.35	-0.29	-0.24	-0.21
Tangible Book Value	-17.32	-15.61	-12.64	-9.83	-7.95	-5.74
Tangible Book Value Per Share	-0.41	-0.39	-0.35	-0.29	-0.24	-0.21

Source: S&P Capital IQ. Standard template. Financial Sources.